GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to analyze the effectiveness of GnRh antagonist in the treatment of early ovarian hyperstimulation syndrome.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
• Treatments: Cetrorelix; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Egg donors

• Volunteers.

• 18-35 years old

• Healthy

• BMI < 30

• OHHS after oocyte retrieval defined as ascitis > 9 cm2 associate to abdominal pain, sickness, abdominal distention,or haematocrit (Ht) >45% an white blood cell count >15,000/mm3 or creatine > 1.2 mg/dl or transaminases > 40 IU/liter

Exclusion Criteria:

• BMI > 30

• Allergy to GnRH antagonist